Stay updated on Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial

Sign up to get notified when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:38:06.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    New study sites were added (Columbus, OH; Rabin Medical Center in Israel; Hospital Universitario Vall de Hebron in Spain) and some existing site identifiers were updated.
    Difference
    0.6%
    Check dated 2026-03-26T11:41:14.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0 and the previous revision v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-19T05:00:00.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a general site version update with no visible changes to study content or navigation.
    Difference
    0.0%
    Check dated 2026-03-12T01:24:06.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision updated to v3.4.2; the funding-lapse notice and the prior revision notice (v3.4.1) were removed.
    Difference
    0.4%
    Check dated 2026-02-11T11:41:40.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    A site-wide funding notice was added and the site version updated to v3.4.1, replacing the previous revision v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T10:17:52.000Z thumbnail image

Stay in the know with updates to Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.